Whitepaper

The US Breast Cancer Market

Market Research

The year 2022 initiated a big bang in the breast cancer awareness segment. Did you know that more than 400,000 women patients live with breast cancer, with 43,250 female and 570 male patients? Breast cancer is a malignant cell growth in the breast tissue and can be caused by inherited genetic mutations of BRCA1 and BRCA2 genes, exposure to radiation, obesity, and other reasons. It impacts both males and females and is growing.

Key Points

  • The average risk of a woman in the United States developing breast cancer sometime in her life is about 13%.
  • Survival rates are climbing as the diagnosis has increased, with the demand for precision medicine all-time high in the breast cancer drugs market.
  • The breast cancer treatment market is a high opportunity segment fuelled by high competition and strong payer perception.
  • If breast cancer is localized, the survival rates can reach up to 99%.

To know more...




Authors

Related Topics

Whitepaper Emergence of Novel Immune Mediated Therapies

White Papers

Emergence of Novel Immune - Mediated Therapies

Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...

Technological  Advancements

White Papers

Future Trends and Technological Advances in Vaccine...

The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...

Trends to Watch 2024 - Media Broadcast Tech

White Papers

2024 Trends to Watch -TV & Video Technology

Media enterprises are steadily witnessing margin pressures attributed to the emergence of newer audience engagement touchpoints such as FAST channels,...

We bring comprehensive data driven insights to everyone, everywhere